Life Sciences
The platform includes language support, call-to-text functionality, a high degree of automation and community outreach features.
Duke-NUS Medical School's LIVE Ventures will bring together scientists and public and private sector entities to commercialize academic research concepts.
Also, a Hong Kong project has received $5 million in funding to develop LLM-run companion robots for the mentally underserved.
The company will use the funds to accelerate its growth, expand the use of its models for different conditions and open an office in Cambridge.
The funding will be used to secure FDA clearance for its benchtop blood-testing system for use in doctor's offices, clinics and pharmacies.
HIMSS24
Emmanuel Bilbault, cofounder and CEO of POSOS, says the company's AI-driven international drug database's use of medication codes enables it to cross-reference EHR data and tailor prescriptions to meet a patient's specific needs.
The company will use the funds to expand its workforce, including its sales team, in order to broaden its biopharma partnerships.
Antidote will use SEQSTER's operating system to improve clinical trial time lines and enhance patient engagement for pharma and life sciences companies.
Continuous Precision Medicine can help confirm a patient's pain medication intake so providers can better manage preventable issues, says the company's CEO and cofounder Steven Walther. However, accurate data is vital to ensuring validity.
The new One Medical Pay-per-visit telehealth service includes pay-per-visit and membership-based models.